The Role of Blood Flow Restriction Therapy in Postop Rehabilitation of Foot and Ankle Injuries

Sponsor
University of Alabama at Birmingham (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05844280
Collaborator
(none)
28
1
2
28
1

Study Details

Study Description

Brief Summary

The purpose of the study is to determine the role of blood flow restriction (BFR) + neuromuscular electrical stimulation (NMES) in improving post-operative physical therapy and recovery after ankle fracture surgery. We expect to see improved muscle strength, less muscle wasting, and improved functional recovery after surgery when making these additions to routine post-operative (postop) physical therapy protocols.

Condition or Disease Intervention/Treatment Phase
  • Procedure: BFR+NMES at therapeutic level
  • Procedure: BFR+NMES at sub therapeutic level
N/A

Detailed Description

Few studies have examined BFR in patients sustaining operative foot and ankle injuries. Due to the weight bearing limitations and prolonged immobilization following these injuries, patients often experience increased time away from work and delays with return to sport. These factors are responsible for the rapid muscle atrophy that occurs in the immediate post injury period because of immobility and disuse. Recently, blood flow restriction (BFR) therapy has been shown to be effective in improving muscle strength and preventing atrophy when combined with low load resistance training physical therapy programs.7,8 Neuromuscular electrical stimulation (NMES) is an adjunctive agent that has been show to augment the effects of BFR alone.4 The null hypothesis is that a 2 week BFR + NMES + low load resistance training program in patients age >= 18 recovering from foot and ankle surgery will have no effect on short term (2 weeks postop) lower extremity muscle hypertrophy or atrophy, patient pain and satisfaction, or functional recovery after foot and ankle surgery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
28 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Role of Blood Flow Restriction Therapy in Postop Rehabilitation of Foot and Ankle Injuries
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Aug 1, 2025
Anticipated Study Completion Date :
Dec 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control Group

receiving physical therapy with BFR+NMES devices used at sub-therapeutic levels

Procedure: BFR+NMES at sub therapeutic level
This means that the BFR tourniquet and the NMES device will be at such low settings as to not create the treatment effect but subject will have the equipments on their thigh during exercise

Experimental: Treatment Group

receiving physical therapy with BFR+NMES devices used at settings that are deemed by prior studies to be therapeutic

Procedure: BFR+NMES at therapeutic level
This group will receive therapy with BFR+NMES devices used at settings that are deemed by prior studies to be therapeutic.

Outcome Measures

Primary Outcome Measures

  1. Assess for calf muscle atrophy as measured by calf circumference [2 weeks postop]

    Calf circumference will be measured using a measuring tape

  2. Assess for calf muscle atrophy as measured by hand held dynamometry [2 weeks postop]

    Hand held Dynamometry will be used to measure the length-tension relationship of the muscle in pounds

Secondary Outcome Measures

  1. Patient tolerance of the BFR treatment using the Visual Analogue Pain Scale. [2 weeks postop]

    The Visual Analogue Pain Scale is used during the beginning, midpoint, and end of a session. This scale ranges from 0-10 which 0 being "no pain" and 10 being "worst pain"

  2. Patient tolerance of the BFR treatment using the the Borg Rating of Perceived Exertion f [2 weeks postop]

    The Borg Rating of Perceived Exertion will be used for each session and exercise. This rating ranges from 6-20 with 6 being no exertion at all, and 20 being maximum effort

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • isolated, closed low-energy rotational ankle fracture without prior surgery or implants to injured area
Exclusion Criteria:
  • history of Deep Vein Thrombosis in affected extremity

  • history of significant cardiac disease defined as a recent stent placement in past

  • history of peripheral arterial disease

  • history of sickle cell disease

  • history of coagulopathy

  • presenting to surgery >14 days after injury

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Alabama at Birmingham Birmingham Alabama United States 35243

Sponsors and Collaborators

  • University of Alabama at Birmingham

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Michael Johnson, Principal Investigator, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT05844280
Other Study ID Numbers:
  • IRB-300009735
First Posted:
May 6, 2023
Last Update Posted:
May 6, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 6, 2023